These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4613878)

  • 1. [Toxigenicity and bacteriophages of Clostridium botulinum].
    Oguma K
    Nihon Saikingaku Zasshi; 1974 Jul; 29(4):665-9. PubMed ID: 4613878
    [No Abstract]   [Full Text] [Related]  

  • 2. Phage-conversion of toxigenicity in Clostridium botulinum types C and D.
    Iida H; Oguma K; Inoue K
    Jpn J Med Sci Biol; 1974 Apr; 27(2):101-3. PubMed ID: 4601039
    [No Abstract]   [Full Text] [Related]  

  • 3. [Toxigenicity and bacteriophage in Clostridium botulinum (author's transl)].
    Iida H
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():31-44. PubMed ID: 800280
    [No Abstract]   [Full Text] [Related]  

  • 4. Phage-conversion of toxigenicity in Clostridium botulinum types C and D.
    Inoue K; Iida H
    Jpn J Med Sci Biol; 1971 Feb; 24(1):53-6. PubMed ID: 4931809
    [No Abstract]   [Full Text] [Related]  

  • 5. Bacteriophages and Toxigencity in Clostridium Botulinum types C and D.
    Oguma K; Iida H; Inove K
    Schweiz Med Wochenschr; 1975 Dec; 105(51):548-52. PubMed ID: 766180
    [No Abstract]   [Full Text] [Related]  

  • 6. Adsorption of Clostridium botulinum cultures of phage controlling type C botulinum toxin production.
    Oguma K; Iida H; Sugiyama H
    Jpn J Med Sci Biol; 1979 Apr; 32(2):125-6. PubMed ID: 396393
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacteriophage and toxigenicity in Clostridium botulinum: an additional evidence for phage conversion.
    Oguma K; Iida H; Inoue K
    Jpn J Microbiol; 1973 Sep; 17(5):425-6. PubMed ID: 4587764
    [No Abstract]   [Full Text] [Related]  

  • 8. High and low toxin production by a non-toxigenic strain of Clostridium botulinum type C following infection with type C phages of different passage history.
    Oguma K; Iida H
    J Gen Microbiol; 1979 May; 112(1):203-6. PubMed ID: 383896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phage conversion of toxigenicity in Clostridium botulinum].
    Khotenko SG; Perova EV; Golikov VI; Bulatova TI; Il'iashenko BN
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Aug; (8):25-8. PubMed ID: 7004020
    [No Abstract]   [Full Text] [Related]  

  • 10. The stability of toxigenicity in Clostridium botulinum types C and D.
    Oguma K
    J Gen Microbiol; 1976 Jan; 92(1):67-75. PubMed ID: 1107486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: Bacteriophages and toxigenicity in Clostridium botulinum types C and D.
    Oguma K; Iida H; Inoue K
    Jpn J Med Sci Biol; 1975 Feb; 28(1):63-6. PubMed ID: 1099282
    [No Abstract]   [Full Text] [Related]  

  • 12. Adsorption to Clostridium botulinum cultures of phage controlling type C botulinum toxin production.
    Oguma K; Sugiyama H
    Proc Soc Exp Biol Med; 1978 Oct; 159(1):61-4. PubMed ID: 362423
    [No Abstract]   [Full Text] [Related]  

  • 13. [Toxin production and phage in Clostridium botulinum].
    Iida H
    Nihon Saikingaku Zasshi; 1985 Sep; 40(5):827-34. PubMed ID: 3908743
    [No Abstract]   [Full Text] [Related]  

  • 14. The origin, structure, and pharmacological activity of botulinum toxin.
    Simpson LL
    Pharmacol Rev; 1981 Sep; 33(3):155-88. PubMed ID: 6119708
    [No Abstract]   [Full Text] [Related]  

  • 15. C2 toxin production by Clostridium botulinum type C strains producing no C1 toxin.
    Nakamura S; Serikawa T; Yamakawa K; Nishida S; Kozaki S; Sakaguchi G
    Jpn J Med Sci Biol; 1979 Apr; 32(2):128-9. PubMed ID: 396395
    [No Abstract]   [Full Text] [Related]  

  • 16. Production of trypsin-activable toxic components by Clostridium botulinum types C and D [proceedings].
    Nakane A; Oguma K; Shiozaki M; Iida H
    Jpn J Med Sci Biol; 1978 Apr; 31(2):166-9. PubMed ID: 355684
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bacteriophages and bacteriocins of Clostridium botulinum].
    Donets IuI
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jun; (6):12-7. PubMed ID: 354284
    [No Abstract]   [Full Text] [Related]  

  • 18. [Production of the trypsin-activable toxin by Clostridium botulinum type C and D strains (author's transl)].
    Nakane A
    Nihon Saikingaku Zasshi; 1977 Nov; 32(6):805-11. PubMed ID: 342740
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ultrastructure of Clostridium botulinum type E during the process of toxin formation].
    Lysenko AI; Cherniavskiĭ VI; Kulakova GS; Iskritskiĭ GV
    Mikrobiol Zh; 1973; 35(3):308-12. PubMed ID: 4598684
    [No Abstract]   [Full Text] [Related]  

  • 20. Observations on bacteriophages of Clostridium botulinum type C isolates from different sources and the role of certain phages in toxigenicity.
    Hariharan H; Mitchell WR
    Appl Environ Microbiol; 1976 Jul; 32(1):145-58. PubMed ID: 61735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.